Search Within

Kenneth Ho-Ming Yu

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (30)
  2. Journal Article (27)
Groups
  1. Center for Pancreatic Cancer Research (57)
  2. Department of Medicine (57)
  3. Epidemiology and Biostatistics (57)
  4. Gastrointestinal Oncology Service (57)
  5. Solid Tumor Oncology Division (57)
  6. Biostatistics Service (54)

More Groups

People
  1. Eileen O'Reilly (56)
  2. Marinela Capanu (44)
  3. David Kelsen (30)
  4. Anna Varghese (28)
  5. Joanne Chou (27)
  6. Maeve Lowery (23)

More People

Years
  1. 2024 (5)
  2. 2023 (5)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Cancer (6)
  3. Clinical Cancer Research (5)
  4. Annals of Oncology (2)
  5. Clinical Colorectal Cancer (2)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (28)
  2. Wiley Blackwell (7)
  3. American Association for Cancer Research (5)
  4. Oxford University Press (4)
  5. Elsevier Inc. (3)
  6. MDPI (2)

More Publishers

Results (57)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Precision medicine for pancreatic cancer: Characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease
    Journal Article

    Keane, F.; Chou, J. F.; Walch, H.; Schoenfeld, J.; Singhal, A.; Cowzer, D.; Harrold, E.; O'Connor, C. A.; Park, W.; Varghese, A.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes
    Meeting Abstract

    Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication
    Journal Article

    Singh, I.; Chou, J. F.; Capanu, M.; Park, J.; Yu, K. H.; Varghese, A. M.; Park, W.; Zervoudakis, A.; Keane, F.; Rolston, V. S.; more...
    Pancreatology (2024)

    Fulltext@MSK | Save
  • Salvage ablative radiotherapy for isolated local recurrence of pancreatic adenocarcinoma following definitive surgery
    Journal Article

    Dee, E. C.; Ng, V. C.; O’Reilly, E. M.; Wei, A. C.; Lobaugh, S. M.; Varghese, A. M.; Zinovoy, M.; Romesser, P. B.; Wu, A. J.; Hajj, C.; more...
    Journal of Clinical Medicine (2024)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer
    Meeting Abstract

    Tuli, R.; Keane, F.; Schoenfeld, J. D.; O'Connor, C.; White, C.; Chou, J. F.; Schwartz, C.; Larsen, M.; Brenner, R.; Park, W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO)
    Meeting Abstract

    Keane, F.; Balogun, F.; O'Connor, C.; Crowley, F.; Chan, A.; Cowzer, D.; Chou, J. F.; Park, W.; Varghese, A. M.; Yu, K. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase II trial of maximal ablative irradiation because of encasement (MAIBE) for patients with potentially resectable locally advanced pancreatic cancer
    Meeting Abstract

    Reyngold, M.; Wei, A.; O'Reilly, E. M.; D'Angelica, M. I.; Drebin, J. A.; Soares, K.; Kingham, T. P.; Balachandran, V. P.; Varghese, A. M.; Park, W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save